Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-10 2:15 pm Sale |
2024-03-28 | 13G | Formula One Group FWONA |
VANGUARD INDEX FUNDS | 863,941 3.600% |
-1,919,170 (-68.96%) |
Filing History |
| 2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Formula One Group FWONA |
VANGUARD INDEX FUNDS | 2,783,111 11.610% |
2,783,111 (New Position) |
Filing History |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | 1895 Bancorp of Wisconsin, Inc. BCOW |
VANGUARD INDEX FUNDS | 450,277 7.370% |
450,277 (New Position) |
Filing History |
| 2022-02-10 08:32 am Sale |
2021-12-31 | 13G | Research Solutions, Inc. RSSS |
VANGUARD INDEX FUNDS | 597,094 2.230% |
-1,134,806 (-65.52%) |
Filing History |
| 2022-02-10 08:32 am Sale |
2021-12-31 | 13G | Perma-Pipe International Holdings, Inc. PPIH |
VANGUARD INDEX FUNDS | 342,184 4.240% |
-129,715 (-27.49%) |
Filing History |
| 2022-02-10 08:22 am Sale |
2021-12-31 | 13G | LifeVantage Corporation LFVN |
VANGUARD INDEX FUNDS | 712,453 5.380% |
-203,376 (-22.21%) |
Filing History |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Daré Bioscience, Inc. DARE |
VANGUARD INDEX FUNDS | 254,671 3.990% |
29,641 (+13.17%) |
Filing History |
| 2022-02-09 3:24 pm Sale |
2021-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
VANGUARD INDEX FUNDS | 402 2.420% |
-343 (-46.04%) |
Filing History |
| 2022-02-09 3:15 pm Sale |
2021-12-31 | 13G | 180 Life Sciences Corp. ATNF |
VANGUARD INDEX FUNDS | 2,643 2.950% |
-171 (-6.08%) |
Filing History |
| 2021-07-12 10:21 am Sale |
2021-06-30 | 13G | Grosvenor Capital Management, L.P. GCMG |
VANGUARD INDEX FUNDS | 996,143 2.340% |
-3,411,230 (-77.40%) |
Filing History |
| 2021-07-12 10:21 am Sale |
2021-06-30 | 13G | Grosvenor Capital Management, L.P. GCMG |
VANGUARD INDEX FUNDS | 845,600 1.980% |
-3,561,773 (-80.81%) |
Filing History |
| 2021-05-27 12:27 pm Sale |
2021-01-29 | 13G | Grosvenor Capital Management, L.P. GCMG |
VANGUARD INDEX FUNDS | 4,407,373 10.800% |
-427,283 (-8.84%) |
Filing History |
| 2021-05-27 12:25 pm Purchase |
2020-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
VANGUARD INDEX FUNDS | 4,834,656 11.850% |
762,819 (+18.73%) |
Filing History |
| 2021-05-27 12:24 pm Purchase |
2020-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
VANGUARD INDEX FUNDS | 4,071,837 9.980% |
4,071,837 (New Position) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | Daré Bioscience, Inc. DARE |
VANGUARD INDEX FUNDS | 225,030 7.110% |
225,030 (New Position) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | Research Solutions, Inc. RSSS |
VANGUARD INDEX FUNDS | 1,731,900 6.600% |
1,731,900 (New Position) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | LifeVantage Corporation LFVN |
VANGUARD INDEX FUNDS | 915,829 6.420% |
915,829 (New Position) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | 180 Life Sciences Corp. ATNF |
VANGUARD INDEX FUNDS | 2,814 5.930% |
2,814 (New Position) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | Perma-Pipe International Holdings, Inc. PPIH |
VANGUARD INDEX FUNDS | 471,899 5.780% |
6,871 (+1.48%) |
Filing History |
| 2021-02-08 10:37 am Purchase |
2020-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
VANGUARD INDEX FUNDS | 746 5.010% |
746 (New Position) |
Filing History |